ArticleThe Lancet. Child & adolescent health2023

Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial.

Eric M Thompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.